azelaic acid 15% gel + azelaic acid 15% gel
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Papulopustular Rosacea
Conditions
Papulopustular Rosacea
Trial Timeline
Jan 1, 2007 → Jun 1, 2007
NCT ID
NCT00417937About azelaic acid 15% gel + azelaic acid 15% gel
azelaic acid 15% gel + azelaic acid 15% gel is a approved stage product being developed by Bayer for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT00417937. Target conditions include Papulopustular Rosacea.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00417937 | Approved | Completed |
Competing Products
18 competing products in Papulopustular Rosacea